Vivani Medical
VANI
44 hedge funds and large institutions have $9.48M invested in Vivani Medical in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 20 closing their positions.
514% more call options, than puts
Call options by funds: $129K | Put options by funds: $21K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.12% less ownership
Funds ownership: 0.7% → 0.58% (-0.12%)
13% less capital invested
Capital invested by funds: $10.9M → $9.48M (-$1.43M)
24% less funds holding
Funds holding: 58 → 44 (-14)
43% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 14
70% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 20
Top Buyers
| 1 |
Millennium Management
New York
|
+$162K |
| 2 |
ECM
Element Capital Management
New York
|
+$133K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$84.2K |
| 4 |
Goldman Sachs
New York
|
+$68.4K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$59.1K |
Top Sellers
| 1 |
BlackRock
New York
|
-$676K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$295K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$277K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$259K |
| 5 |
State Street
Boston,
Massachusetts
|
-$217K |
VANI Hedge Fund Activity: Q2 2017 in Review
44 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q2 2017, worth a combined $9.48M — down 13% from $10.9M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of VANI and 6 opened new positions — a net loss of 14 holders — while 14 trimmed existing stakes and 8 added.
The largest buyer was Millennium Management, adding an estimated $162K. The largest seller was BlackRock, cutting an estimated $676K.
- 44 institutional investors held Vivani Medical (VANI) as of Q2 2017, down from 58 in Q1 2017.
- Funds reported $9.48M of Vivani Medical stock for Q2 2017, down 13% quarter-over-quarter.
- 6 funds opened new Vivani Medical positions in Q2 2017 and 20 closed out, a net change of -14 holders.
- The largest Vivani Medical buyer in Q2 2017 was Millennium Management, an estimated $162K added.
- The largest Vivani Medical seller in Q2 2017 was BlackRock, an estimated $676K sold.
Based on aggregated 13F filings for Q2 2017.